168 related articles for article (PubMed ID: 25138900)
1. Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.
Price TJ; Segelov E; Burge M; Haller DG; Tebbutt NC; Karapetis CS; Punt CJ; Pavlakis N; Arnold D; Gibbs P; Shapiro JD
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1477-93. PubMed ID: 25138900
[TBL] [Abstract][Full Text] [Related]
2. Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.
Price TJ; Thavaneswaran S; Burge M; Segelov E; Haller DG; Punt CJ; Arnold D; Karapetis CS; Tebbutt NC; Pavlakis N; Gibbs P; Shapiro JD
Expert Rev Anticancer Ther; 2016 May; 16(5):557-71. PubMed ID: 27010906
[TBL] [Abstract][Full Text] [Related]
3. Current opinion on optimal treatment for colorectal cancer.
Price TJ; Segelov E; Burge M; Haller DG; Ackland SP; Tebbutt NC; Karapetis CS; Pavlakis N; Sobrero AF; Cunningham D; Shapiro JD
Expert Rev Anticancer Ther; 2013 May; 13(5):597-611. PubMed ID: 23617351
[TBL] [Abstract][Full Text] [Related]
4. Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.
Price TJ; Tebbutt NC; Karapetis CS; Segelov E; Pavlakis N; Cunningham D; Sobrero AF; Haller DG; Shapiro JD
Clin Colorectal Cancer; 2010 Jan; 9(1):8-14. PubMed ID: 20100683
[TBL] [Abstract][Full Text] [Related]
5. Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers.
Kasi PM; Hubbard JM; Grothey A
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):273-6. PubMed ID: 25579664
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
7. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
Heinemann V; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Stauch M; Scheithauer W; Hielscher J; Scholz M; Müller S; Link H; Niederle N; Rost A; Höffkes HG; Moehler M; Lindig RU; Modest DP; Rossius L; Kirchner T; Jung A; Stintzing S
Lancet Oncol; 2014 Sep; 15(10):1065-75. PubMed ID: 25088940
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.
Beatty GL; Giantonio BJ
Expert Rev Anticancer Ther; 2008 May; 8(5):683-8. PubMed ID: 18471041
[TBL] [Abstract][Full Text] [Related]
9. Third-line therapy for metastatic colorectal cancer.
Gundgaard MG; Soerensen JB; Ehrnrooth E
Cancer Chemother Pharmacol; 2008 Jan; 61(1):1-13. PubMed ID: 17786445
[TBL] [Abstract][Full Text] [Related]
10. [Recent Advances in Systemic Chemotherapy for Metastatic Colorectal Cancer].
Miyamoto Y; Oki E; Saeki H; Maehara Y; Baba H
Gan To Kagaku Ryoho; 2016 Jan; 43(1):15-23. PubMed ID: 26809522
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
12. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
Lee JJ; Chu E
Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
[TBL] [Abstract][Full Text] [Related]
13. Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.
Marino D; Leone F; D'Avanzo F; Ribero D; Capussotti L; Aglietta M
Crit Rev Oncol Hematol; 2014 Dec; 92(3):218-26. PubMed ID: 24985058
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for mitomycin C in metastatic colorectal cancer?
Dimou A; Syrigos KN; Saif MW
Expert Opin Investig Drugs; 2010 Jun; 19(6):723-35. PubMed ID: 20433364
[TBL] [Abstract][Full Text] [Related]
15. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
16. Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.
Siu LL; Shapiro JD; Jonker DJ; Karapetis CS; Zalcberg JR; Simes J; Couture F; Moore MJ; Price TJ; Siddiqui J; Nott LM; Charpentier D; Liauw W; Sawyer MB; Jefford M; Magoski NM; Haydon A; Walters I; Ringash J; Tu D; O'Callaghan CJ
J Clin Oncol; 2013 Jul; 31(19):2477-84. PubMed ID: 23690424
[TBL] [Abstract][Full Text] [Related]
17. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J; Sastre J; Arnold D; Österlund P; Greil R; Van Cutsem E; von Moos R; Viéitez JM; Bouché O; Borg C; Steffens CC; Alonso-Orduña V; Schlichting C; Reyes-Rivera I; Bendahmane B; André T; Kubicka S;
Lancet Oncol; 2013 Jan; 14(1):29-37. PubMed ID: 23168366
[TBL] [Abstract][Full Text] [Related]
18. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
Jain VK; Hawkes EA; Cunningham D
Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
[TBL] [Abstract][Full Text] [Related]
19. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
20. Optimal treatment of metastatic colorectal cancer.
Pessino A; Sobrero A
Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
